tiprankstipranks
CVS Health Corp (CVS)
NYSE:CVS

CVS Health Stock Analysis & Ratings

Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

Risk Analysis

Main Risk Category
Ability to SellRisks related to the company’s ability to sell goods and services

Product Monthly Users

Number of people who visit CVS Health websites
Desktop Users
Mobile Users

CVS FAQ

What was CVS Health’s price range in the past 12 months?
CVS Health lowest stock price was $80.82 and its highest was $111.25 in the past 12 months.
    What is CVS Health’s market cap?
    Currently, no data Available
    What is CVS Health’s price target?
    The average price target for CVS Health is $118.92. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
    The highest analyst price target is $130.00 ,the lowest forecast is $102.00. The average price target represents 16.59% Increase from the current price of $102.
      What do analysts say about CVS Health?
      CVS Health’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 12 Wall Streets Analysts.
        When is CVS Health’s upcoming earnings report date?
        CVS Health’s upcoming earnings report date is Nov 08, 2022 which is in 91 days.
          How were CVS Health’s earnings last quarter?
          CVS Health released its earnings results on Aug 03, 2022. The company reported $2.4 earnings per share for the quarter, beating the consensus estimate of $2.183 by $0.217.
            Is CVS Health overvalued?
            According to Wall Street analysts CVS Health’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
              Does CVS Health pay dividends?
              CVS Health pays a Quarterly dividend of $0.55 which represents an annual dividend yield of 2.1%. CVS Health’s last Quarterly dividend payment was on Aug 01, 2022. CVS Health’s upcoming ex-dividend date is Jul 21, 2022
                What is CVS Health’s EPS estimate?
                CVS Health’s EPS estimate is $2.01.
                  How many shares outstanding does CVS Health have?
                  CVS Health has 1,311,309,100 shares outstanding.
                    What happened to CVS Health’s price movement after its last earnings report?
                    CVS Health reported an EPS of $2.4 in its last earnings report, beating expectations of $2.183. Following the earnings report the stock price went up 6.302%.
                      Which hedge fund is a major shareholder of CVS Health?
                      Among the largest hedge funds holding CVS Health’s share is Dodge & Cox. It holds CVS Health’s shares valued at 1B.

                        ---

                        CVS Health Stock Analysis

                        The CVS Health stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                        Learn more about TipRanks Smart Score

                        Company Description

                        CVS Health Corp

                        Headquartered in Rhode Island and founded in 1963, CVS Health Corp. is a healthcare company in the U.S. that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; Aetna, a health insurance provider, among many other brands.

                        ---
                        Similar Stocks
                        Company
                        Price & Change
                        Follow
                        Cigna
                        Laboratory
                        Quest Diagnostics
                        R1 RCM
                        Agilon Health

                        Popular Stocks

                        ---
                        What's Included in PREMIUM?
                        Make informed decisions based on Top Analysts' activity
                        Know what industry insiders are buying
                        Get actionable alerts from top Wall Street Analysts
                        Find out before anyone else which stock is going to shoot up
                        Get powerful stock screeners & detailed portfolio analysis